Distinct roles for isoforms of the catalytic subunit of class-IA PI3K in the regulation of behaviour of murine embryonic stem cells

Journal of Cell Science

Volumn 122, Issue 13, 2009, Pages 2311-2321

  Kingham, Emmajayne ^a   Welham, Melanie ^a  

^a University of Bath   (United Kingdom)

Author keywords

Cell proliferation; Embryonic stem cells; PI3 kinase; Pluripotency; Signal transduction

Indexed keywords

INSULIN; LEUKEMIA INHIBITORY FACTOR; P110 ALPHA; P110 BETA; P110 DELTA; PHOSPHATIDYLINOSITOL 3 KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVE SITE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL PROLIFERATION; EMBRYONIC STEM CELLS; ENZYME INHIBITORS; HOMEODOMAIN PROTEINS; ISOENZYMES; MICE; PROTEIN SUBUNITS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

MURINAE;

EID: 69449087260     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.046557     Document Type: Article

References (66)

1. Aksoy, I., Sakabedoyan, C., Bourillot, P. Y., Malashicheva, A. B., Mancip, J., Knoblauch, K., Afanassieff, M. and Savatier, P. (2007). Self-renewal of murine embryonic stem cells is supported by the serine/ threonine kinases pim-1 and pim-3. Stem Cells 25, 2996-3004.
2. Armstrong, L., Hughes, O., Yung, S., Hyslop, L., Stewart, R., Wappler, I., Peters, H., Walter, T., Stojkovic, P., Evans, J. et al. (2006). The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Gen. 15, 1894-1913.
3. Bi, L., Okabe, I., Bernard, D. J., Wynshaw-Boris, A. and Nussbaum, R. L. (1999). Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J. Biol. Chem. 274, 10963-10968.
4. Bi, L., Okabe, I., Bernard, D. J. and Nussbaum, R. L. (2002). Early embryonic lethality in mice deficient in the p110beta catalytic subunit of PI 3-kinase. Mamm. Genome 13, 169-172.
5. Boeuf, H., Hauss, C., DeGraeve, F., Baran, N. and Kedinger, C. (1997). Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J. Cell Biol. 138, 1207-1217.
6. Boiani, M. and Schoeler, H. R. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell. Biol. 6, 872-881.
7. Bone, H. K., Damiano, T., Bartlett, S., Perry, A., Letchford, J., Sanchez Ripoll, Y., Nelson, A. S. and Welham, M. J. (2008). Involvement of glycogen synthase kinase-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Chem. Biol. 16, 15-27.
8. Bottenstein, J. E. and Sato, G. H. (1979). Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76, 514-517.
9. Brewer, G. J. and Cotman, C. W. (1989). Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res. 494, 65-74.
10. Brewer, G. J., Torricelli, J. R., Evege, E. K. and Prive, P. J. (1993). Optimized survival of hippocampal neurons in B27-Supplemented neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35, 567-576.
11. Burdon, T., Stracey, C., Chambers, I., Nichols, J. and Smith, A. (1999). Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210, 30-43.
12. Burdon, T., Smith, A. and Savatier, P. (2002). Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol. 12, 432-438.
13. Cantrell, D. A. (2001). Phosphoinositide 3-kinase signalling pathways. J. Cell Sci 114, 1439-1445.
14. Cartwright, P., McLean, C., Sheppard, A., Rivett, D., Jones, K. and Dalton, S. (2005). LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 132, 885-896.
15. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655.
16. Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M., Vrana, J., Jones, K., Grotewold, L. and Smith, A. (2007). Nanog safeguards pluripotency and mediates germline development. Nature 450, 1230-1234.
17. Chaussade, C., Rewcastle, G. W., Kendall, J. D., Denny, W. A., Cho, K., Gronning, L. M., Chong, M. L., Anagnostou, S. H., Jackson, S. P., Daniele, N. et al. (2007). Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. Biochem. J. 404, 449-458.
18. Ciraolo, E., Iezzi, M., Marone, R., Marengo, S., Curcio, C., Costa, C., Azzolino, O., Gonella, C., Rubinetto, C., Wu, H. et al. (2008). Phosphoinositide 3-Kinase p110β activity: key role in metabolism and mammary gland cancer but not development. Sci. Signal. 1, 1-12.
19. Condliffe, A., Davidson, K., Anderson, K., Ellson, C., Crabbe, T., Okkenhaug, K., Vanhaesebroeck, B., Turner, M., Webb, L., Wymann, M. et al. (2005). Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. Blood 106, 1432-1440.
20. Cristoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S. C., Waterfield, M. D., Backer, J. M. and Zerial, M. (1999). Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat. Cell Biol. 1, 249-252.
21. Evans, M. J. and Kaufman, M. H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156.
22. Foukas, L. C., Claret, M., Pearce, W., Okkenhaug, K., Meek, S., Peskett, E., Sancho, S., Smith, A. J. H., Withers, D. J. and Vanhaesebroeck, B. (2006). Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441, 366-370.
23. Guillermet-Guibert, J., Bjorklof, K., Salpekar, A., Gonella, C., Ramadani, F., Bilancio, A., Meek, S., Smith, A. J. H., Okkenhaug, K. and Vanhaesebroeck, B. (2008). The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc. Natl. Acad. Sci. USA 105, 8292-8297.
24. Hayakawa, M., Kaizawa, H., Moritomo, H., Koizumi, T., Ohishi, T., Okada, M., Ohta, M., Tsukamoto, S. i., Parker, P., Workman, P. et al. (2006). Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110[alpha] inhibitors. Bioorg. Med. Chem. 14, 6847-6858.
25. Hennessy, B., Smith, D., Ram, P., Lu, Y. and Mills, G. (2005). Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov. 4, 988-1004.
26. Hooshmand-Rad, R., Hajkova, L., Klint, P., Karlsson, R., Vanhaesebroeck, B., Claesson-Welsh, L. and Heldin, C. H. (2000). The PI 3-kinase isoforms p110 alpha and p110 beta have differential roles in PDGF- and insulin-mediated signaling. J. Cell Sci. 113, 207-214
27. Ivanova, N., Dobrin, R., Lu, R., Kotenko, I., Lervorse, J., DeCoste, C., Schafer, X., Lun, Y. and Lemischka, I. R. (2006). Dissecting self-renewal in stem cells with RNA interference. Nature 442, 533-538.
28. Jackson, S., Schoenwaelder, S., Goncalves, I., Nesbitt, W., Yap, C., Wright, C., Kenche, V., Anderson, K., Dopheide, S., Yuan, Y. et al. (2005). PI 3-kinase p110beta a new target for antithrombotic therapy. Nat. Med. 11, 507-514.
29. Jirmanova, L., Afanassieff, M., Gobert-Gosse, S., Markossian, S. and Savatier, P. (2002). Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21, 5515-5528.
30. Kang, S., Denley, A., Vanhaesebroeck, B. and Vogt, P. K. (2006). Oncogenic transformation induced by the p110 beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. Proc. Natl. Acad. Sci. USA 103, 1289-1294.
31. Knight, Z. A., Gonzalez, B., Feldman, M. E., Zunder, E. R., Goldenberg, D. D., Williams, O., Loewith, R., Stokoe, D., Balla, A. and Toth, B. (2006). A pharmacological map of the PI3-K family defines a role for p110[alpha] in insulin signaling. Cell 125, 733-747.
32. Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J., Meloche, S. and Smith, A. (2007). FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage committment. Development 134, 2895-2902.
33. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642.
34. Murakami, M., Ichisaka, T., Maeda, M., Oshiro, N., Hara, K., Edenhofer, F., Kiyama, H., Yonezawa, K. and Yamanaka, S. (2004). mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24, 6710-6718.
35. Niwa, H. (2007). How is pluripotency determined and maintained? Development 134, 635-646.
36. Niwa, H., Burdon, T., Chambers, I. and Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12, 2048-2060.
37. Okkenhaug, K., Bilancio, A., Farjot, G., Priddle, H., Sancho, S., Peskett, E., Pearce, W., Meek, S. E., Salpekar, A., Waterfield, M. D. et al. (2002). Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297, 1031-1034.
38. Paling, N. R., Wheadon, H., Bone, H. K. and Welham, M. J. (2004). Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem. 279, 48063-48070.
39. Papakonstanti, E. A., Zwaenepoel, O., Bilancio, A., Burns, E., Nock, G. E., Houseman, B., Shokat, K., Ridley, A. J. and Vanhaesebroeck, B. (2008). Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages J. Cell Sci. 121, 4124-4133.
40. Patrucco, E., Notte, A., Barberis, L., Selvetella, G., Maffei, A., Brancaccio, M., Marengo, S., Russo, G., Azzolino, O., Rybalkin, S. D. et al. (2004). PI3Kgamma modulates the cardiac response to chronic pressure overlaod by distinct kinase-dependent and -independent effects. Cell 118, 375-387.
41. Pebay, A., Wong, R. C., Pitson, S. M., Wolvetang, E. J., Peh, G. S., Filipczyk, A., Koh, K. L., Tellis, I., Nguyen, L. T. and Pera, M. F. (2005). Essential roles of sphongosine-1-phosphate and platelet-derived growth factor in the maintenance of human embryonic stem cells. Stem Cells 23, 1541-1548.
42. Pritsker, M., Ford, N., Jenq, H. and Lemischka, I. (2006). Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 103, 6946-6951.
43. Pyle, A., Lock, L. and Donovan, P. (2006). Neurotrophins mediate human embryonic stem cell survival. Nat. Biotech. 24, 344-350.
44. Riley, J. K., Carayannopoulos, M. O., Wyman, A. H., Chi, M., Ratajczak, C. K. and Moley, K. H. (2005). The PI3K/Akt pathway is present and functional in the preimplantation mouse embryo. Dev. Biol. 284, 377-386.
45. Riley, J. K., Carayannopoulos, M. O., Wyman, A. H., Chi, M. and Moley, K. H. (2006). Phosphatidylinositol 3-Kinase activity is critical for glucose metabolism and embryo survival in murine blastocysts. J. Biol. Chem. 281, 6010-6019.
46. Roche, S., Koegl, M. and Courtneidge, S. A. (1994). The phosphatidylinositol 3-kinase-Alpha is required for DNA-synthesis induced by some, but not all, growth-factors. Proc. Natl. Acad. Sci. USA 91, 9185-9189.
47. Roche, S., Downward, J., Raynal, P. and Courtneidge, S. A. (1998). A function for phosphatidylinositol 3-kinase beta (p85 alpha-p110 beta) in fibroblasts during mitogenesis: Requirement for insulin- and lysophosphatidic acid-mediated signal transduction. Mol. Cell. Biol. 18, 7119-7129.
48. Rommel, C., Clarke, B. A., Zimermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D. and Glass, D. J. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
49. Rottenberg, H. and Wu, S. L. (1998). Quantitative assay by flow cytometry of the mitochondrial membrane potential in intact cells. BBA-Mol. Cell Res. 1404, 393-404.
50. Sadhu, C., Masinovsky, B., Dick, K., Sowell, C. G. and Staunton, D. E. (2003). Essential role of phosphoinositide 3-kinase {delta} in Neutrophil directional movement. J. Immunol. 170, 2647-2654.
51. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P. and Brivanlou, A. H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55-63.
52. Smith, A. G. (2001). Embryo-derived stem cells: of mice and men. Ann. Rev. Cell Dev. Biol. 17, 435-462.
53. Stavridis, M., Lunn, J. S., Collins, B. J. and Storey, K. G. (2007). A discrete period of FGF-induced Erk1/2 signalling is required fro vertebrate neural specification. Development 134, 2889-2894.
54. Storm, M., Bone, H. K., Beck, C. G., Bourillot, P. Y., Schreiber, V., Damiano, T., Nelson, A., Savatier, P. and Welham, M. J. (2007). Regulation of Nanog expression by phosphoinositide 3-kinase -dependent signalling in murine embryonic stem cells. J. Biol. Chem. 282, 6265-6273.
55. Sun, H., Lesche, R., Li, D. M., Liliental, J., Zhang, H., Gao, J., Gavrilova, N., Mueller, B., Liu, X. and Wu, H. (1999). PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 96, 6199-6204.
56. Takahashi, K., Mitsui, K. and Yamanaka, S. (2003). Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423, 541-545.
57. Vanhaesebroeck, B. and Waterfield, M. D. (1999). Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253, 239-254.
58. Vanhaesebroeck, B., Welham, M. J., Kotani, K., Stein, R., Warne, P. H., Zvelebil, M. J., Higashi, K., Volinia, S., Downward, J. and Waterfield, M. D. (1997). P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc. Natl. Acad. Sci. USA 94, 4330-4335.
59. Vanhaesebroeck, B., Jones, G. E., Allen, W. E., Zicha, D., Hooshmand-Rad, R., Sawyer, C., Wells, C., Waterfield, M. D. and Ridley, A. J. (1999). Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat. Cell Biol. 1, 69-71.
60. Vanhaesebroeck, B., Rohn, J. L. and Waterfield, M. D. (2004). Gene targeting: attention to detail. Cell 118, 274-276.
61. Watanabe, S., Umehara, H., Murayama, K., Okabe, M., Kimura, T. and Nakano, K. (2006). Activation of Akt signalling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 25, 2697-2707.
62. Welham, M. J., Dechert, U., Leslie, K. B., Jirik, F. and Schrader, J. W. (1994). Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3b-kinase. J. Biol. Chem. 269, 23764-23768.
63. Welham, M. J., Storm, M. P., Kingham, E. and Bone, H. K. (2007). Phosphoinositide 3-kinases and regulation of embryonic stem cell fate. Biochem. Soc. Trans. 35, 225-228.
64. Williams, M. R., Arthur, J. S., Balendran, A., van der Kaay, J., Poli, V., Cohen, P. and Alessi, D. R. (2000). The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr. Biol. 10, 439-448.
65. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M. and Smith, A. (2003a). Conversion of embryonic stem cell into neuroectoderma precursos in adherent monoculture. Nat. Biotech. 21, 183-186.
66. Ying, Q. L., Nichols, J., Chambers, I. and Smith, A. (2003b). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 115, 281-292.